SCHEMBL7672154

SCHEMBL7672154

COC(=O)c1cc(C#N)cc2cc(OC)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP3A4 P08684 2/20 0.46
PLA2G2A P14555 7/20 0.46
NR4A2 P43354 1/20 0.45
KDM4E B2RXH2 3/20 0.44
HPGDS O60760 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
NQO1 P15559 1/20 0.42
GAA P10253 2/20 0.41
MTNR1A P48039 1/20 0.41
MAPT P10636 2/20 0.40
ALOX15 P16050 2/20 0.40
CNR1 P21554 1/20 0.40
CASP1 P29466 1/20 0.40
CNR2 P34972 1/20 0.40
CASP7 P55210 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673256 0.87 KDM4E (0.49) CYP3A4KDM4EHPGDSL3MBTL1NQO1
SCHEMBL7671086 0.87 MAOB (0.53) KDM4EL3MBTL1GAAMAPTCASP1
SCHEMBL2483533 0.81 KDM4E (0.52) CYP1A2NR4A2KDM4EMAPTSMN1; SMN2
SCHEMBL2237855 0.75 MTNR1A (0.56) CYP1A2CYP2D6CYP2C9CYP2C19PLA2G2A
SCHEMBL7672321 0.74 CA1 (0.46) KDM4EMAPTALDH1A1HPGDNPSR1
SCHEMBL27806564 0.74 KDM4E (0.49) CYP1A2CYP2D6CYP2C9CYP2C19PLA2G2A
SCHEMBL7669452 0.73 TSHR (0.47) KDM4EL3MBTL1GAAMAPTALOX15
SCHEMBL17197313 0.73 CYP1A2 (0.56) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL4316682 0.73 CYP1A2 (0.56) CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4
SCHEMBL26882759 0.72 KDM4E (0.57) CYP1A2CYP2D6CYP2C9CYP2C19PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365602-B1 FOR THERAPY OF DEPRESSION, ANXIETY, ASTHMA, PAIN, INFLAMMATION, URINARY INCONTINENCE AND OTHER DISEASE CONDITIONS ASTRA ZENECA AB (SE) 2002-04-02 US disclosed
EP-1097137-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-05-09 EP disclosed
WO-2000002859-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed